ReviewTranslational andrology and urology2025
Complications and management of penile enhancement procedures.
Review in Translational andrology and urology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Subcutaneous penile silicone sleeve implants for penile augmentation: a systematic review and meta-analysis.International journal of impotence research · 2026Review
- Penile skin necrosis after complex penile surgery with synthetic grafts: a case report.Translational andrology and urology · 2026Article
- DART-VAG: initial clinical experience with a novel autologous technique for penile girth augmentation.World journal of urology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Demand for penile enhancement-driven by cosmetic and psychological goals-is rising, and complications are increasingly encountered in urologic practice. This review offers practical, procedure-focused guidance on diagnosing and managing adverse events after injectable fillers, self-injection of foreign substances, dermal matrices, autologous fat transfer, and the subcutaneous silicone Penuma implant. Hyaluronic acid (HA) is the most commonly used filler and, when applied with standardized, low-volume protocols, generally has lower complication rates than polylactic acid (PLA), polymethylmethacrylate (PMMA), silicone, or nonmedical self-injected materials. Typical HA-related issues include migration, nodules, Tyndall effect, phimosis, and infection; management emphasizes early massage/modeling, warm compresses, judicious hyaluronidase for confirmed HA, antibiotics with drainage for abscess, and selective surgical excision for refractory nodules. Permanent fillers and self-injected substances are associated with granuloma, necrosis, infection, lymphedema, and disfiguring inflammation; these often require wide excision down to Buck's fascia with reconstructive strategies such as split-thickness skin grafts or scrotal/dartos flaps. For dermal matrix and fat transfer, complications include edema, hematoma, infection (commonly
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.